Replimune Group, Inc. (REPL) Misses Q4 EPS by 235c

Replimune Group, Inc. (NASDAQ: REPL) reported Q4 EPS of ($3.07), $2.35 worse than the analyst estimate of ($0.72).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Boeing wins $121 million Navy contract for P-8A upgrades
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink